Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.29 and traded as low as $0.24. Northwest Biotherapeutics shares last traded at $0.25, with a volume of 3,653,052 shares traded.
Northwest Biotherapeutics Stock Performance
The company has a market cap of $338.66 million, a PE ratio of -3.12 and a beta of -0.51. The company’s 50 day moving average price is $0.27 and its 200-day moving average price is $0.29.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Read More
- Five stocks we like better than Northwest Biotherapeutics
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- About the Markup Calculator
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- Dividend Payout Ratio Calculator
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
